, au cours d'un suivi moyen de 8 ans, nous avons relevé 7 complications neurologiques chez 6 patients : 4 AVC, 2 abcès, 1 AIT. A noter qu'un patient a eu un AVC et un abcès cérébral

S. A. Abdalla, Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease, Journal of Medical Genetics. 17 juin, vol.43, issue.2, pp.97-110, 2005.

C. Westermann, A. F. Rosina, V. De-vries, P. A. Coteau, and . De, The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: A family screening, American Journal of Medical Genetics. 1 févr, vol.116, issue.4, pp.324-332, 2003.

A. Bideau, H. Plauchu, G. Brunet, and J. Robert, Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence, Popul. sept, vol.44, issue.1, pp.3-22, 1989.

G. Lesca, E. Genin, C. Blachier, C. Olivieri, F. Coulet et al., Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients, Eur J Hum Genet. juin, vol.16, issue.6, pp.742-751, 2008.

H. Plauchu and S. Dupuis-girod, Rev Prat. 20 sept, vol.59, issue.7, pp.899-903, 2009.

J. Mcdonald, R. Pyeritz, M. P. Adam, H. H. Ardinger, R. A. Pagon et al., Hereditary Hemorrhagic Telangiectasia, 1993.

J. B. Hoag, P. Terry, S. Mitchell, D. Reh, and C. A. Merlo, An epistaxis severity score for hereditary hemorrhagic telangiectasia, The Laryngoscope. avr, vol.120, issue.4, pp.838-881, 2010.

M. Loaëc, S. Morinière, M. Hitier, O. Ferrant, H. Plauchu et al., Psychosocial quality of life in hereditary haemorrhagic telangiectasia patients, Rhinology. juin, vol.49, issue.2, pp.164-171, 2011.

S. Dupuis-girod, A. Ambrun, E. Decullier, A. Fargeton, A. Roux et al., Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia: A Randomized Clinical Trial, JAMA, vol.06, issue.9, pp.934-976, 2016.

C. L. Shovlin and M. Letarte, Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms, Thorax. 1 août, vol.54, issue.8, pp.714-743, 1999.

C. L. Shovlin, J. E. Jackson, K. B. Bamford, I. H. Jenkins, A. R. Benjamin et al., Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia, Thorax. 1 mars, vol.63, issue.3, pp.259-66, 2008.

V. Cottin, D. Gamondes, A. Schuller, M. Coudurier, S. Dupuis-girod et al., Near-fatal haemorrhage from pulmonary arteriovenous malformation in HHT with increased cardiac output, European Respiratory Review. 1 sept, vol.18, issue.113, pp.190-192, 2009.

S. A. Abdalla, C. J. Gallione, R. J. Barst, E. M. Horn, J. A. Knowles et al., Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia, European Respiratory Journal. mars, vol.23, issue.3, pp.373-380, 2004.

E. Buscarini, C. Danesino, C. Olivieri, G. Lupinacci, D. Grazia et al., Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia --results of extensive screening, Ultraschall Med. sept, vol.25, issue.5, pp.348-55, 2004.

E. Buscarini, H. Plauchu, G. Tsao, G. White, R. I. Sabbà et al., Liver involvement in hereditary hemorrhagic telangiectasia: consensus recommendations. Liver Int, vol.26, pp.1040-1046, 2006.

G. Garcia-tsao, Liver involvement in hereditary hemorrhagic telangiectasia (HHT), Journal of Hepatology. mars, vol.46, issue.3, pp.499-507, 2007.

S. Dupuis-girod, I. Ginon, J. Saurin, D. Marion, E. Guillot et al., Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output, JAMA. 7 mars, vol.307, issue.9, pp.948-55, 2012.

W. Brinjikji, V. N. Iyer, V. Yamaki, G. Lanzino, H. J. Cloft et al., Neurovascular Manifestations of Hereditary Hemorrhagic Telangiectasia: A Consecutive Series of 376 Patients during 15 Years, American Journal of Neuroradiology. 1 août, vol.37, issue.8, pp.1479-86, 2016.

A. E. Hosman, E. M. De-gussem, W. Balemans, A. Gauthier, C. Westermann et al., Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience, Pediatr Pulmonol, vol.52, issue.9, pp.1206-1217, 2017.

R. Al-shahi, A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults, Brain, vol.124, issue.10, pp.1900-1926, 2001.

M. N. Woodall, M. Mcgettigan, R. Figueroa, J. R. Gossage, and C. H. Alleyne, Cerebral vascular malformations in hereditary hemorrhagic telangiectasia, J Neurosurg. janv, vol.120, issue.1, pp.87-92, 2014.

W. Brinjikji, V. N. Iyer, G. Lanzino, K. R. Thielen, and C. P. Wood, Natural history of brain capillary vascular malformations in hereditary hemorrhagic telangiectasia patients, J Neurointerv Surg. janv, vol.9, issue.1, pp.26-34, 2017.

A. Poisson, A. Vasdev, F. Brunelle, H. Plauchu, S. Dupuis-girod et al., Acute paraplegia due to spinal arteriovenous fistula in two patients with hereditary hemorrhagic telangiectasia, Eur J Pediatr. févr, vol.168, issue.2, pp.135-144, 2009.

V. Cottin, Manifestations vasculaires pulmonaires de la maladie de Rendu Osler, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02679249

H. Plauchu and A. Bideau, Épidémiologie et constitution d'un registre de population à propos d'une concentration géographique d'une maladie héréditaire rare. Population (French Edition), juill, vol.39, issue.4/5, p.765, 1984.

C. L. Shovlin, A. E. Guttmacher, E. Buscarini, M. E. Faughnan, R. H. Hyland et al., Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome), Am J Med Genet. 6 mars, vol.91, issue.1, pp.66-73, 2000.

B. Sopeña, M. T. Pérez-rodríguez, D. Portela, A. Rivera, M. Freire et al., High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia, European Journal of Internal Medicine. avr, vol.24, issue.3, pp.30-34, 2013.

L. David, J. Feige, and S. Bailly, Emerging role of bone morphogenetic proteins in angiogenesis, Cytokine & Growth Factor Reviews. juin, vol.20, issue.3, pp.203-215, 2009.

V. Cottin, S. Dupuis-girod, G. Lesca, and J. Cordier, Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease), Respiration, vol.74, issue.4, pp.361-78, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02663665

B. Girerd, D. Montani, F. Coulet, B. Sztrymf, A. Yaici et al., Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 ( ALK1 ) Mutation, American Journal of Respiratory and Critical Care Medicine. 15 avr, vol.181, issue.8, pp.851-61, 2010.

S. Dupuis-girod, G. S. Decullier, E. Lesca, G. Cottin, V. Faure et al., Hemorrhagic hereditary telangiectasia (Rendu-Osler disease) and infectious diseases: an underestimated association, Clin Infect Dis. 15 mars, vol.44, issue.6, pp.841-846, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02667848

A. Guilhem, C. Malcus, B. Clarivet, H. Plauchu, and S. Dupuis-girod, Immunological abnormalities associated with hereditary haemorrhagic telangiectasia, J Intern Med, vol.274, issue.4, pp.351-62, 2013.

K. S. Aagaard, A. D. Kjeldsen, P. M. Tørring, and A. Green, Comorbidity among HHT patients and their controls in a 20 years follow-up period, Disponible sur, vol.13, 2018.

W. Wu, C. Lu, J. Shen, X. Zhang, and S. Zhang, Paradoxical Coronary Embolisms as a Presentation of Hereditary Hemorrhagic Telangiectasia, Journal of the American College of Cardiology. janv, vol.63, issue.3, p.5, 2014.

C. J. Heiberger, M. J. Brown, and D. Sandhu, Pulmonary Arteriovenous Malformations: A Rare Cause of Ischemic Stroke, Cureus. 15 juill, vol.11, issue.7, p.5141, 2019.

A. Guilhem, M. Ciudad, V. Leguy-seguin, N. B. Berthier, S. Maillet et al., Implication des lymphocytes T angiogéniques au cours de la maladie de Rendu-Osler. La Revue de Médecine Interne, juin, vol.40, pp.98-107, 2019.

G. S. Ashcroft, Bidirectional regulation of macrophage function by TGF-beta, Microbes Infect. déc, vol.1, issue.15, pp.1275-82, 1999.

M. Maniscalco, A. Zedda, S. Faraone, . Laurentiis-g-de, R. Verde et al., Association of Adams-Oliver syndrome with pulmonary arterio-venous malformation in the same family: A further support to the vascular hypothesis, American Journal of Medical Genetics Part A, vol.136, issue.3, pp.269-74, 2005.

K. A. Mcallister, K. M. Grogg, D. W. Johnson, C. J. Gallione, M. A. Baldwin et al., Endoglin, a TGF-? binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1, Nature Genetics. déc, vol.8, issue.4, pp.345-51, 1994.

D. W. Johnson, J. N. Berg, M. A. Baldwin, C. J. Gallione, I. Marondel et al., Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2, Nature Genetics. juin, vol.13, issue.2, pp.189-95, 1996.

C. J. Gallione, G. M. Repetto, E. Legius, A. K. Rustgi, S. L. Schelley et al., A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4). The Lancet. mars, vol.363, pp.852-861, 2004.

C. Gallione, A. S. Aylsworth, J. Beis, T. Berk, B. Bernhardt et al., Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome, American Journal of Medical Genetics Part A, vol.152, issue.2, pp.333-342, 2010.

W. L. Wooderchak-donahue, J. Mcdonald, B. O'fallon, P. D. Upton, W. Li et al., BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia, The American Journal of Human Genetics. sept, vol.93, issue.3, pp.530-537, 2013.

F. Hernandez, R. Huether, L. Carter, T. Johnston, J. Thompson et al., Mutations in RASA1 and GDF2 identified in patients with clinical features of hereditary hemorrhagic telangiectasia, Hum Genome Var, vol.2, p.15040, 2015.

S. Kroon, R. J. Snijder, M. E. Faughnan, and H. Mager, Systematic screening in hereditary hemorrhagic telangiectasia: a review, Curr Opin Pulm Med, vol.24, issue.3, pp.260-268, 2018.

G. Lesca, H. Plauchu, F. Coulet, S. Lefebvre, G. Plessis et al., Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France, Human Mutation, vol.23, issue.4, pp.289-99, 2004.
URL : https://hal.archives-ouvertes.fr/hal-02675529

T. Karlsson and H. Cherif, Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital, Ups J Med Sci. sept, vol.123, issue.3, pp.153-160, 2018.

P. Bayrak-toydemir, J. Mcdonald, B. Markewitz, S. Lewin, F. Miller et al., Genotypephenotype correlation in hereditary hemorrhagic telangiectasia: Mutations and manifestations*, American Journal of Medical Genetics Part A, vol.140, issue.5, pp.463-70, 2006.

G. Lesca, C. Olivieri, N. Burnichon, F. Pagella, M. Carette et al., Genotypephenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network, Genet Med. janv, vol.9, issue.1, pp.14-22, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00434621

D. H. Best, C. Vaughn, J. Mcdonald, K. Damjanovich, J. R. Runo et al., Mosaic ACVRL1 and ENG mutations in hereditary haemorrhagic telangiectasia patients, Journal of Medical Genetics. 1 mai, vol.48, issue.5, pp.358-60, 2011.

L. Jonker, TGF-? & BMP Receptors Endoglin and ALK1: Overview of their Functional Role and Status as Antiangiogenic Targets, Microcirculation. févr, vol.21, issue.2, pp.93-103, 2014.

F. Lebrin, M. Goumans, L. Jonker, R. Carvalho, G. Valdimarsdottir et al., Endoglin promotes endothelial cell proliferation and TGF-?/ALK1 signal transduction, The EMBO Journal, vol.23, issue.20, pp.4018-4046, 2004.

K. J. Gordon and G. C. Blobe, Role of transforming growth factor-? superfamily signaling pathways in human disease, Biochimica et Biophysica Acta, vol.1782, issue.4, pp.197-228, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00562819

C. L. Shovlin, Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment, Blood Rev, vol.24, issue.6, pp.203-222, 2010.

P. Carmeliet and R. K. Jain, Molecular mechanisms and clinical applications of angiogenesis, Nature. 19 mai, vol.473, issue.7347, pp.298-307, 2011.

S. Bailly, S. Dupuis-girod, and H. Plauchu,

, Med Sci (Paris), vol.26, issue.10, pp.855-60, 2010.

S. Bailly, S. Dupuis-girod, and H. Plauchu,

, Med Sci (Paris), vol.26, issue.10, pp.855-60, 2010.

M. Benzinou, F. F. Clermont, T. Letteboer, J. Kim, S. Espejel et al., Mouse and human strategies identify PTPN14 as a modifier of angiogenesis and hereditary haemorrhagic telangiectasia, Nat Commun. 10 janv, vol.3, p.616, 2012.

L. Harrison, A. Kundra, and P. Jervis, The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review, J Laryngol Otol, vol.132, issue.10, pp.866-71, 2018.

E. Buscarini, L. M. Botella, U. Geisthoff, A. D. Kjeldsen, H. J. Mager et al., Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia, Orphanet J Rare Dis, vol.04, issue.1, p.28, 2019.

M. Nakayama, T. Nawa, T. Chonan, K. Endo, S. Morikawa et al., Prevalence of Pulmonary Arteriovenous Malformations as Estimated by Low-Dose Thoracic CT Screening, Internal Medicine, vol.51, issue.13, pp.1677-81, 2012.

N. Rauh, J. Gurley, and S. Saha, Contemporary Management of Pulmonary Arteriovenous Malformations, Int J Angiol. déc, vol.26, issue.4, pp.205-216, 2017.

A. Contegiacomo, A. Del-ciello, R. Rella, N. Attempati, D. Coppolino et al., Pulmonary arteriovenous malformations: what the interventional radiologist needs to know, Radiol med, vol.17, issue.2019

D. Sur,

J. R. Gossage and G. Kanj, Pulmonary arteriovenous malformations. A state of the art review, Am J Respir Crit Care Med. août, vol.158, issue.2, pp.643-61, 1998.

M. S. Esplin and M. W. Varner, Progression of pulmonary arteriovenous malformation during pregnancy: case report and review of the literature, Obstet Gynecol Surv. avr, vol.52, issue.4, pp.248-53, 1997.

E. M. De-gussem, A. Y. Lausman, A. J. Beder, C. P. Edwards, M. H. Blanker et al., Outcomes of pregnancy in women with hereditary hemorrhagic telangiectasia, Obstet Gynecol. mars, vol.123, issue.3, pp.514-534, 2014.

C. L. Shovlin, A. R. Winstock, A. M. Peters, J. E. Jackson, and J. M. Hughes, Medical complications of pregnancy in hereditary haemorrhagic telangiectasia, QJM. déc, vol.88, issue.12, pp.879-87, 1995.

G. A. Latino, S. Al-saleh, S. Carpenter, and F. Ratjen, The Diagnostic Yield of Rescreening for Arteriovenous Malformations in Children with Hereditary Hemorrhagic Telangiectasia, The Journal of Pediatrics. juill, vol.165, issue.1, pp.197-206, 2014.

A. E. Hosman, E. M. Gussem, . De, W. Balemans, A. Gauthier et al., Screening children for pulmonary arteriovenous malformations: Evaluation of 18 years of experience

P. Pulmonology, , 2017.

S. S. Saboo, M. Chamarthy, S. Bhalla, H. Park, P. Sutphin et al., Pulmonary arteriovenous malformations: diagnosis, Cardiovasc Diagn Ther. juin, vol.8, issue.3, pp.325-362, 2018.

R. I. White, Pulmonary arteriovenous malformations: how do I embolize?, Tech Vasc Interv Radiol. déc, vol.10, issue.4, pp.283-90, 2007.

P. Lacombe, C. Lagrange, A. Beauchet, M. El-hajjam, T. Chinet et al., Diffuse Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia, Chest. avr, vol.135, issue.4, pp.1031-1038, 2009.

P. Lacombe, A. Lacout, P. Marcy, S. Binsse, J. Sellier et al., Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: An overview, Diagnostic and Interventional Imaging. 1 sept, vol.94, issue.9, pp.835-883, 2013.

M. C. Post, M. Van-gent, H. Plokker, C. Westermann, J. C. Kelder et al., Pulmonary arteriovenous malformations associated with migraine with aura, European Respiratory Journal, vol.34, issue.4, pp.882-889, 2009.

S. Dupuis-girod, V. Cottin, and C. L. Shovlin, The Lung in Hereditary Hemorrhagic Telangiectasia, Respiration, vol.94, issue.4, pp.315-345, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02620517

W. E. Stern and H. C. Naffziger, Brain abscess associated with pulmonary angiomatous malformation, Ann Surg, vol.138, issue.4, pp.521-552, 1953.

S. T. Byrne, M. J. Mcdonald, and S. I. Poonnoose, Ten-year follow-up of a patient with Osler-Weber-Rendu syndrome and recurrent cerebral abscess secondary to pulmonary arteriovenous fistula, Journal of Clinical Neuroscience. août, vol.16, issue.8, pp.1095-1101, 2009.

C. Rotenberg, M. Bonay, E. Hajjam, M. Blivet, S. Beauchet et al., Effect of pulmonary arteriovenous malformations on the mechanical properties of the lungs, Disponible sur, vol.17, 2017.

M. E. Faughnan, V. A. Palda, G. Garcia-tsao, U. W. Geisthoff, J. Mcdonald et al., International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia, J Med Genet. févr, vol.48, issue.2, pp.73-87, 2011.
URL : https://hal.archives-ouvertes.fr/hal-02650655

J. A. Parra, J. Bueno, J. Zarauza, C. Farinas-alvarez, J. M. Cuesta et al., Graded contrast echocardiography in pulmonary arteriovenous malformations, European Respiratory Journal. 1 juin, vol.35, issue.6, pp.1279-85, 2010.

V. Vorselaars, S. Velthuis, R. J. Snijder, C. Westermann, J. A. Vos et al., Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia, European Respiratory Journal. juin, vol.47, issue.6, pp.1750-1757, 2016.

S. S. Saboo, M. Chamarthy, S. Bhalla, H. Park, P. Sutphin et al., Pulmonary arteriovenous malformations: diagnosis, Cardiovasc Diagn Ther. juin, vol.8, issue.3, pp.325-362, 2018.

C. Karam, J. Sellier, N. Mansencal, C. Fagnou, S. Blivet et al., Reliability of contrast echocardiography to rule out pulmonary arteriovenous malformations and avoid CT irradiation in pediatric patients with hereditary hemorrhagic telangiectasia, Echocardiography. janv, vol.32, issue.1, pp.42-50, 2015.

T. Chinet, How to follow-up patients with hereditary haemorrhagic telangiectasia and suspected pulmonary arteriovenous malformations, European Respiratory Journal. juin, vol.47, issue.6, pp.1618-1639, 2016.

P. Gazzaniga, E. Buscarini, G. Leandro, L. Reduzzi, M. Grosso et al., Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter?, Eur J Echocardiogr. juin, vol.10, issue.4, pp.513-521, 2009.

S. Velthuis, E. Buscarini, J. R. Gossage, R. J. Snijder, J. J. Mager et al., Clinical Implications of Pulmonary Shunting on Saline Contrast Echocardiography, Journal of the American Society of Echocardiography. 1 mars, vol.28, issue.3, pp.255-63, 2015.

V. Vorselaars, S. Velthuis, R. J. Snijder, C. Westermann, J. A. Vos et al., Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia, Eur Respir J, vol.47, issue.6, pp.1750-1757, 2016.

T. Kawai, M. Shimohira, H. Kan, T. Hashizume, K. Ohta et al., Feasibility of timeresolved MR angiography for detecting recanalization of pulmonary arteriovenous malformations treated with embolization with platinum coils, J Vasc Interv Radiol. sept, vol.25, issue.9, pp.1339-1386, 2014.

A. Aal, A. K. Eason, J. Moawad, S. Mahmoud, K. Hamed et al., Persistent Pulmonary Arteriovenous Malformations: Percutaneous Embolotherapy, Curr Probl Diagn Radiol. nov, vol.47, issue.6, pp.428-464, 2018.

J. S. Pollak, S. Saluja, A. Thabet, K. J. Henderson, N. Denbow et al., Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations, J Vasc Interv Radiol. janv, vol.17, issue.1, pp.35-44, 2006.

H. Cct, K. Gnc, and T. Sa, Embolisation for pulmonary arteriovenous malformation, vol.18, 2012.

C. L. Shovlin, Pulmonary arteriovenous malformations, Am J Respir Crit Care Med. 1 déc, vol.190, issue.11, pp.1217-1245, 2014.

C. Ferro, F. Petrocelli, U. G. Rossi, G. Bovio, M. Dahmane et al., Vascular percutaneous transcatheter embolisation with a new device: Amplatzer vascular plug. La radiologia medica, mars, vol.112, issue.2, pp.239-51, 2007.

R. Ratnani, P. D. Sutphin, V. Koshti, H. Park, M. Chamarthy et al., Retrospective Comparison of Pulmonary Arteriovenous Malformation Embolization with the Polytetrafluoroethylene-Covered Nitinol Microvascular Plug, AMPLATZER Plug, and Coils in Patients with Hereditary Hemorrhagic Telangiectasia, Journal of Vascular and Interventional Radiology. 1 juill, vol.30, issue.7, pp.1089-97, 2019.

M. R. Chamarthy, H. Park, P. Sutphin, G. Kumar, D. Lamus et al., Pulmonary arteriovenous malformations: endovascular therapy, Cardiovasc Diagn Ther. juin, vol.8, issue.3, pp.338-387, 2018.

W. Mouton, H. U. Würsten, B. Kipfer, I. Hof, V. Triller et al.,

, Helv Chir Acta. sept, vol.60, issue.1-2, pp.167-70, 1993.

S. Tellapuri, H. S. Park, and S. P. Kalva, Pulmonary arteriovenous malformations. The International Journal of Cardiovascular Imaging, 2018.

D. Sur,

A. Ratjen, J. Au, S. Carpenter, P. John, and F. Ratjen, Growth of Pulmonary Arteriovenous Malformations in Pediatric Patients with Hereditary Hemorrhagic Telangiectasia, The Journal of Pediatrics. mai, vol.208, pp.279-81, 2019.

K. L. Mowers, L. Sekarski, A. J. White, and R. M. Grady, Pulmonary arteriovenous malformations in children with hereditary hemorrhagic telangiectasia: a longitudinal study, Pulm Circ. sept, vol.8, issue.3, p.2045894018786696, 2018.

I. Clemente, E. J. Ratjen, F. Manson, and D. E. , Utility of MDCT MIP Postprocessing Reconstruction Images in Children With Hereditary Hemorrhagic Telangiectasia, Journal of Computer Assisted Tomography, vol.40, issue.3, pp.375-384, 2016.

J. Chick, S. N. Reddy, R. E. Pyeritz, and S. O. Trerotola, A Survey of Pulmonary Arteriovenous Malformation Screening, Management, and Follow-Up in Hereditary Hemorrhagic Telangiectasia Centers of Excellence, CardioVascular and Interventional Radiology. juill, vol.40, issue.7, pp.1003-1012, 2017.

V. Cottin, H. Plauchu, S. Dupuis-girod, and J. Cordier, Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia: follow-up and pathophysiologic considerations, J Vasc Interv Radiol. juill, vol.18, issue.7, pp.938-947, 2007.
URL : https://hal.archives-ouvertes.fr/hal-02667146

M. C. Post, V. Thijs, W. J. Schonewille, W. Budts, R. J. Snijder et al., Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine, Neurology. 24 janv, vol.66, issue.2, pp.202-207, 2006.

A. D. Kjeldsen, T. R. Møller, K. Brusgaard, P. Vase, and P. E. Andersen, Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia, J Intern Med, vol.258, issue.4, pp.349-55, 2005.

T. Nishida, M. E. Faughnan, T. Krings, M. Chakinala, J. R. Gossage et al., Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: genephenotype correlations, Am J Med Genet A, vol.158, issue.11, pp.2829-2863, 2012.

A. D. Kjeldsen, H. Oxhøj, P. E. Andersen, A. Green, and P. Vase, Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT), J Intern Med. sept, vol.248, issue.3, pp.255-62, 2000.

C. L. Shovlin, B. Chamali, V. Santhirapala, J. A. Livesey, G. Angus et al., Ischaemic Strokes in Patients with Pulmonary Arteriovenous Malformations and Hereditary Hemorrhagic Telangiectasia: Associations with Iron Deficiency and Platelets. Brusgaard K, éditeur, PLoS ONE. 19 févr, vol.9, issue.2, p.88812, 2014.

M. E. Faughnan, J. T. Granton, and L. H. Young, The pulmonary vascular complications of hereditary haemorrhagic telangiectasia, Eur Respir J. mai, vol.33, issue.5, pp.1186-94, 2009.

P. E. Andersen, P. M. Tørring, S. Duvnjak, O. Gerke, H. Nissen et al., Pulmonary arteriovenous malformations: a radiological and clinical investigation of 136 patients with long-term follow-up, Clinical Radiology. nov, vol.73, issue.11, pp.951-958, 2018.

M. Van-gent, M. C. Post, J. Luermans, R. J. Snijder, C. Westermann et al., Screening for pulmonary arteriovenous malformations using transthoracic contrast echocardiography: a prospective study, European Respiratory Journal. 1 janv, vol.33, issue.1, pp.85-91, 2009.

W. Hundt, M. Kalinowski, A. Kiessling, J. T. Heverhagen, B. Eivazi et al., Novel approach to complex pulmonary arteriovenous malformation embolization using detachable coils and Amplatzer vascular plugs, European Journal of Radiology. 1 mai, vol.81, issue.5, pp.732-740, 2012.

M. E. Faughnan, Y. W. Lui, J. A. Wirth, R. A. Pugash, D. A. Redelmeier et al., Diffuse pulmonary arteriovenous malformations: characteristics and prognosis, Chest. janv, vol.117, issue.1, pp.31-39, 2000.

M. Babaker, S. Breault, C. Beigelman, R. Lazor, N. Aebischer et al., Endovascular treatment of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia, Swiss Med Wkly, vol.145, p.14151, 2015.

W. Brinjikji, G. A. Latino, A. Parvinian, A. Gauthier, R. Pantalone et al., Diagnostic Yield of Rescreening Adults for Pulmonary Arteriovenous Malformations, Journal of Vascular and Interventional Radiology

D. Sur,

D. J. Ryan, T. M. O'connor, M. M. Murphy, and A. P. Brady, Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia, Clinical Radiology. mars, vol.72, issue.3, pp.236-277, 2017.

J. J. Mager, T. Overtoom, H. Blauw, J. Lammers, and C. Westermann, Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients, J Vasc Interv Radiol. mai, vol.15, issue.5, pp.451-457, 2004.

M. Remy-jardin, P. Dumont, P. Brillet, P. Dupuis, A. Duhamel et al., Pulmonary arteriovenous malformations treated with embolotherapy: helical CT evaluation of long-term effectiveness after 2-21-year follow-up, Radiology. mai, vol.239, issue.2, pp.576-85, 2006.

M. R. Chamarthy, H. Park, P. Sutphin, G. Kumar, D. Lamus et al., Pulmonary arteriovenous malformations: endovascular therapy, Cardiovasc Diagn Ther. juin, vol.8, issue.3, pp.338-387, 2018.

C. Bélanger, C. Chartrand-lefebvre, G. Soulez, M. E. Faughnan, M. R. Tahir et al., Pulmonary arteriovenous malformation (PAVM) reperfusion after percutaneous embolization: Sensitivity and specificity of non-enhanced CT, Eur J Radiol. janv, vol.85, issue.1, pp.150-157, 2016.

P. E. Andersen, S. Duvnjak, O. Gerke, and A. D. Kjeldsen, Long-Term Single-Center Retrospective Follow-Up After Embolization of Pulmonary Arteriovenous Malformations Treated Over a 20-year Period: Frequency of Re-canalization with Various Embolization Materials and Clinical Outcome, Cardiovasc Intervent Radiol. août, vol.42, issue.8, pp.1102-1111, 2019.

J. S. Pollak, S. Saluja, A. Thabet, K. J. Henderson, N. Denbow et al., Clinical and Anatomic Outcomes after Embolotherapy of Pulmonary Arteriovenous Malformations, Journal of Vascular and Interventional Radiology. janv, vol.17, pp.35-45, 2006.

C. S. Woodward, R. E. Pyeritz, J. L. Chittams, and S. O. Trerotola, Treated Pulmonary Arteriovenous Malformations: VASCULAR AND INTERVENTIONAL RADIOLOGY, vol.269, p.8, 2013.

D. Gamondès, S. Si-mohamed, V. Cottin, S. Gonidec, L. Boussel et al., Vein Diameter on Unenhanced Multidetector CT Predicts Reperfusion of Pulmonary Arteriovenous Malformation after Embolotherapy, Eur Radiol. août, vol.26, issue.8, pp.2723-2732, 2016.

M. M. Haddad, E. C. Bendel, W. S. Harmsen, V. N. Iyer, and S. Misra, Smoking Significantly Impacts Persistence Rates in Embolized Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia, Radiology. sept, vol.292, issue.3, pp.762-70, 2019.

N. R. Curnes, B. Desjardins, R. Pyeritz, J. Chittams, D. Sienko et al., Lack of Growth of Small (?2 mm Feeding Artery) Untreated Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia, Journal of Vascular and Interventional Radiology. 1 août, vol.30, issue.8, pp.1259-64, 2019.

S. Felix, S. Jeannin, C. Goizet, J. B. Thambo, G. S. Plauchu et al., Stroke following pulmonary arteriovenous fistula embolization in a patient with HHT, Neurology. 9 déc, vol.71, issue.24, pp.2012-2016, 2008.

E. De-cillis, N. Burdi, A. S. Bortone, D. 'agostino, D. Fiore et al., Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic teleangiectasia, Curr Pharm Des, vol.12, issue.10, pp.1243-1251, 2006.

E. Ribeiro, J. Cogez, E. Babin, F. Viader, and G. Defer, Stroke in hereditary hemorrhagic telangiectasia patients. New evidence for repeated screening and early treatment of pulmonary vascular malformations: two case reports, BMC Neurol. 9 juill, vol.11, p.84, 2011.

J. Etievant, S. Si-mohamed, N. Vinurel, S. Dupuis-girod, E. Decullier et al., Pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia: Correlations between computed tomography findings and cerebral complications, Eur Radiol. mars, vol.28, issue.3, pp.1338-1382, 2018.

W. Brinjikji, D. M. Nasr, C. P. Wood, and V. N. Iyer, Pulmonary Arteriovenous Malformations Are Associated with Silent Brain Infarcts in Hereditary Hemorrhagic Telangiectasia Patients, Cerebrovasc Dis, vol.44, issue.3-4, pp.179-85, 2017.

R. J. Holzer and C. L. Cua, Pulmonary Arteriovenous Malformations and Risk of Stroke, Cardiology Clinics. 1 mai, vol.34, issue.2, pp.241-247, 2016.

, PNDS 2018 Maladie de Rendu Osler, 2018.

R. Smith-bindman and J. M. Boone, Introduction to the Special Issue: Radiation Dose Optimization-Improving the Safety of CT, Journal of the American College of Radiology. 1 mars, vol.11, issue.3, pp.229-259, 2014.

J. D. Mathews, A. V. Forsythe, Z. Brady, M. W. Butler, S. K. Goergen et al., Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians, BMJ. 21 mai, vol.346, p.2360, 2013.

K. Hanneman, M. E. Faughnan, and V. Prabhudesai, Cumulative radiation dose in patients with hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations, Can Assoc Radiol J. mai, vol.65, issue.2, pp.135-175, 2014.

, ANNEXES Serment

, de mes chers condisciples et devant l'effigie d'Hippocrate, je promets et je jure, au nom de l'Etre suprême, d'être fidèle aux lois de l'honneur et de la probité dans l'exercice de la médecine

, Je donnerai mes soins gratuits à l'indigent et n'exigerai jamais un salaire audessus de mon travail

, Admis (e) dans l'intérieur des maisons, mes yeux ne verront pas ce qui s'y passe, ma langue taira les secrets qui me seront confiés, et mon état ne servira pas à corrompre les moeurs

, Respectueux (se) et reconnaissant (e) envers mes Maîtres, je rendrai à leurs enfants l'instruction que j'ai reçue de leurs pères

, Que les hommes m'accordent leur estime si je suis fidèle à mes promesses. Que je sois couvert (e) d'opprobre et méprisé (e) de mes confrères si j'y manque